A cold dread settled deep in Elara’s stomach, colder than the late-night air seeping through her apartment window. Doctor Alvarez’s words echoed, a relentless hammer against her fragile hope: “Weeks, perhaps months.” Leo’s small, pale face flashed behind her eyes. He was sleeping now, innocent of the ticking clock, tucked into his superhero sheets. Fingers trembled as Elara navigated the sterile, overwhelming world of medical research. Her laptop glowed, a harsh beacon in the dim living room. Empty coffee cups littered the table, a testament to hours already lost. She typed, “Xylos Syndrome experimental gene therapy.” Link after link. Scientific papers. Clinical trials. Most were dead ends, or worse, trials already concluded, results inconclusive. Her heart rate picked up with every promising headline, only to plummet with every disclaimer. Searching for the Sterling Foundation had led her down a rabbit hole of outdated information. It seemed the specific gene therapy Leo needed wasn't funded by them anymore, or perhaps it was a different strain entirely. Frustration mounted, a hot, bitter taste in her mouth. She re-read the specialist’s referral notes, scanning for any detail she might have missed. There it was, scrawled in neat, tight script: *“Dr. Aris Thorne. Thorne Medical Foundation. Pioneer in Xylos gene therapy. Clinical trials ongoing.”* Thorne. The name hit her like a physical blow, a sudden, sharp pain in her chest. Not Gideon Sterling, but Thorne. Julian Thorne. The man responsible. Her breath hitched. A decade had passed, but the name still clawed at her, a jagged memory of shattered dreams and a family torn apart. Swallowing hard, Elara forced her fingers back to the keyboard. She couldn’t afford to freeze now. Not when Leo’s life hung in the balance. Julian Thorne. His name brought up a cascade of links, not just medical. Corporate reports. Philanthropic endeavors. Political donations. The man was everywhere, his influence vast and inescapable. She clicked on the Thorne Medical Foundation website. It was sleek, modern, almost offensively pristine. Pictures of smiling children, doctors in crisp white coats, state-of-the-art facilities. A sickening wave of irony washed over her. This man, who had profited from her family’s downfall, now ran a foundation dedicated to saving lives. Digging deeper, Elara found the specific gene therapy mentioned by Dr. Alvarez. It was indeed active, listed as Phase III, with limited enrollment. An experimental drug, highly advanced, and devastatingly expensive. Eligibility criteria scrolled across the screen. A knot formed in her stomach. Leo qualified on paper, but the sheer exclusivity of it felt insurmountable. Funding. Sponsorship. The words blurred into a cruel mockery. How could she, Elara Vance, approach Julian Thorne for help? The very idea was anathema. Her jaw tightened. Memories, long suppressed, began to surface. Sunlight streaming through her father’s office window. The scent of old paper and leather. Her father’s booming laugh, a sound that now only existed in echo. He had built Vance Technologies from the ground up. A true innovator, passionate and relentless. Until Thorne. Julian Thorne, with his predatory smile and his even more predatory legal team. He’d seen an opportunity, a weakness, and he’d exploited it without mercy. Elara remembered the hushed conversations, the late-night calls. Her mother’s tear-streaked face. The slow, agonizing dissolution of everything they had built. Her father’s spirit had broken first. The company, his life’s work, snatched away. Then his health, ravaged by stress and despair. He was gone within a year of the takeover, leaving behind a legacy erased and a family in ruins. All thanks to Thorne Capital, Julian Thorne’s behemoth corporation. Now, a decade later, the universe had a dark sense of humor. The only path to saving her son led straight to the man who had destroyed her family. She scrolled past the foundation’s impressive board of directors, past testimonials from grateful families. Each face, each story, a fresh stab of injustice. This wasn’t about philanthropy to Thorne. This was about power. Image. Control. Every fiber of her being screamed in protest. But then, Leo’s face appeared in her mind again. His tiny hand wrapped around her finger. His bright, inquisitive eyes. Pride. Bitterness. Those were luxuries she couldn’t afford. Not when her son’s life was at stake. Weariness gnawed at her, but a new resolve hardened her features. She needed to know everything. Every detail of Thorne’s empire, every vulnerability, every avenue. Hours bled into the early morning. The apartment grew cold. Elara didn’t notice. She delved deeper, moving from the pristine foundation website to news archives, corporate filings, old press releases. She stumbled upon an article from ten years ago. A small, almost forgotten piece, buried deep in a financial news aggregator. Clicking it open, the grainy image materialized on her screen. A faded newspaper clipping. The headline screamed in bold, archaic font: *“Thorne Capital Acquires Vance Technologies in Hostile Takeover – CEO Vance Steps Down.”* Below it, a picture. Julian Thorne, younger, undeniably handsome, stood beside a grim-faced board member, a triumphant, almost smug smile playing on his lips. His eyes, even in the faded print, held a calculating glint. A surge of molten bitterness flooded Elara’s mouth. Her knuckles turned white, gripping the edge of the desk. The memories weren't just surfacing; they were drowning her. The humiliation, the helplessness, the profound loss. She stared at his face, the face of the man who had orchestrated her family’s ruin. Could she really swallow her pride and beg for his help? For Leo, she knew she had to try. But the thought was a searing brand on her soul.

Chapter 2: The Name She Hates